| 26.62 Data as of Jun 17 |  -0.97 / -3.52%Today’s Change | 22.02 Today|||52-Week Range 38.27 | -2.31% Year-to-Date |
| Myriad Genetics Inc. (MYGN): Today's Featured Diversified Services Laggard Jun 17 / TheStreet.com | Mid-Afternoon Market Update: Walter Energy Plummets as Oil Posts a Strong Rally Jun 14 / Benzinga |
| German Court Rules in Favor of MDT - Analyst Blog Jun 17 / Zacks.com | LIFE Continues Korean Expansion - Analyst Blog Jun 14 / Zacks.com |
| Myriad: End to Legal Battle over Patents - Analyst Blog Jun 17 / Zacks.com | Afternoon Market Losers Jun 14 / Benzinga |
| DaVita, Myriad RBM Announce Biomarker Research Collaboration Jun 17 / Benzinga | Why Myriad Genetics Shares Swooned Again Jun 14 / MotleyFool.com |
| Supreme Court Lets the Gene Out of the Bottle Jun 14 / MotleyFool.com | Mid-Day Market Update: Stocks Move Lower, Groupon Rises on Analyst Upgrade Jun 14 / Benzinga |
| Previous close | 27.59 |
| Today’s open | 28.01 |
| Day’s range | 26.51 - 28.67 |
| Volume | 4,571,536 |
| Average volume (3 months) | 1,760,109 |
| Market cap | $2.1B |
| Dividend yield | -- |
| Earnings growth (last year) | +18.18% |
| Earnings growth (this year) | +28.37% |
| Earnings growth (next 5 years) | +16.00% |
| Revenue growth (last year) | +23.36% |
| P/E ratio | 16.8 |
| Price/Sales | 4.05 |
| Price/Book | 3.46 |
| Today’s change | Today’s % change | |
|---|---|---|
| CLVSClovis Oncology Inc | +1.76 | +2.62% |
| MNKDMannkind Corp | -0.17 | -2.20% |
| VPHMViroPharma Inc | +1.71 | +6.30% |
| OPKOPKO Health Inc | +0.24 | +3.51% |
| Next reporting date | August 20, 2013 |
| EPS forecast (this quarter) | $0.44 |
| Annual revenue (last year) | $496.0M |
| Annual profit (last year) | $112.2M |
| Net profit margin | 22.61% |
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Peter D. Meldrum |
Executive Vice President- International Operations Gary A. King, MBA |
Corporate headquarters Salt Lake City, Utah |
.
